Research Directions | September 2023
25 September 2023Monthly insights on Australian and international MND research by our Executive Research Director, Dr Gethin Thomas – September 2023 edition.
Monthly insights on Australian and international MND research by our Executive Research Director, Dr Gethin Thomas – September 2023 edition.
The PBAC is currently accepting submissions regarding the inclusion of Edaravone (RADICAVA®) on the Pharmaceutical Benefits Scheme.
We are excited to announce the recipients of the Daniel McLoone Major Research Initiative jointly funded by MND Research Australia (MNDRA) and FightMND.
invested in research to find treatments and a cure for motor neurone disease
Australians currently living with MND who we support through investment in research, care and advocacy
evidence-based MND information materials developed to advance care and quality of life